Insider Trading & Ownership - Shreedhar Vijay

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Shreedhar Vijay
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-21
Sale
2021-06-23
4:09 pm
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
6,200$5.1585$31,983165,735
(Direct)
View
2021-03-22
Sale
2021-03-23
6:06 pm
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
1,051$5.5$5,781169,435
(Direct)
View
2021-02-01
Sale
2021-02-01
9:37 pm
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
4,514$6.39$28,84495,486
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-11-24
Disposition
2021-11-24
4:09 pm
N/A
2029-06-06
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
185,000$00
(Direct)
View
2021-11-24
Equity Swap
2021-11-24
4:09 pm
N/A
N/A
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
186,786$00
(Direct)
View
2021-11-24
Option Award
2021-11-24
4:09 pm
N/A
N/A
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
18,750$00
(Direct)
View
2021-03-02
Option Award
2021-03-03
4:59 pm
N/A
N/A
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
75,000$0170,486
(Direct)
View
2020-03-17
Option Award
2020-03-19
4:24 pm
N/A
2030-03-16
Adamas Pharmaceuticals IncADMSShreedhar Vijay
Chief Commercial Officer
71,250$0142,500
(Direct)
View